Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. - Wikidata - wikimedia - TriplyDB

Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling.

Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling.

http://www.wikidata.org/entity/Q35015752

about

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP Adiponectin signaling and function in insulin target tissues Adiponectin, driver or passenger on the road to insulin sensitivity?Gastric inhibitory polypeptide receptor methylation in newly diagnosed, drug-naïve patients with type 2 diabetes: a case-control study Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis Cot/tpl2 participates in the activation of macrophages by adiponectin.Adiponectin isoforms differentially affect gene expression and the lipidome of primary human hepatocytes Benefits of healthy adipose tissue in the treatment of diabetes.Adiponectin signaling in the liver The role of adiponectin in cancer: a review of current evidence.Mapping MKP-3/FOXO1 interaction and evaluating the effect on gluconeogenesis.Development of second generation peptides modulating cellular adiponectin receptor responses.The Polycomb protein, Bmi1, regulates insulin sensitivity The short isoform of the ubiquitin ligase NEDD4L is a CREB target gene in hepatocytes.Pentoxifylline alleviates cardiac ischemia and dysfunction following experimental angina in insulin resistance Ceramides as modulators of cellular and whole-body metabolism Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytes Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes.Role of ceramides in nonalcoholic fatty liver disease Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment.Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2.Adipose tissue biology and cardiomyopathy: translational implications.Feeding a Modified Fish Diet to Bottlenose Dolphins Leads to an Increase in Serum Adiponectin and Sphingolipids Potential mechanisms of exercise in gestational diabetes Evaluation of Lipid Profile in Second and Third Trimester of Pregnancy.Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production.Eicosapentaenoic acid ameliorates hyperglycemia in high-fat diet-sensitive diabetes mice in conjunction with restoration of hypoadiponectinemia.Metabolic function of the CTRP family of hormones.5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.Royal jelly improves hyperglycemia in obese/diabetic KK-Ay mice Adipokines and insulin action: A sensitive issue.Adiponectin: mechanistic insights and clinical implications.Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver.Adipose tissue, hormones, and treatment of type 1 diabetes.Coming full circle in diabetes mellitus: from complications to initiation.Regulation of adiponectin multimerization, signaling and function.Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism.

P2860

Q22251081-81CE5C56-7C49-479D-AD2C-7DF1896E3B9F Q26753354-23C1839C-AF27-46AF-A04E-45D1B3173B27 Q26827971-C949CB07-AE75-4EBF-8FBB-85098AC3F433 Q28533735-895E80B2-0C22-40E1-933D-FFDC4F14BE50 Q28584013-9D0AFFF1-1ED1-4F94-9A54-CF086CDF7B16 Q33613182-5928D04D-E9A3-4767-AAE2-9983B3F7CFE7 Q33912675-8341675D-8489-434D-BFCE-158F92C89897 Q34023537-D9311A38-4A15-4176-8E0B-162D6A54A63C Q34125349-3550BA70-953A-4F38-A17A-AC9AEDD1A4A1 Q34271986-C5CB59B4-8656-495B-91D6-DBDD5E8F8D70 Q34358243-4A5C5E80-A4AA-45C7-9AED-C35469701FF7 Q34360125-D14561E5-0C64-4471-AE7C-D58FE4FC4092 Q34436643-33FE14B5-46E5-45DB-A796-9D0C929DBF72 Q35023606-EA7142CF-E0FA-42EE-85FC-E3B88168D4F0 Q35175820-E10F8CC3-83F0-4D32-A1F7-2F5E84DF5063 Q35484864-4AB3CC56-B379-43FF-8A40-EEA5A5791695 Q35601144-1BDBA5A9-71DB-416A-8E76-79533A24675E Q35683960-064BE352-B8D8-40F6-A102-B7187FF8F492 Q35859504-359F6785-CABF-4B3E-AC40-E1405C5E7AEA Q36129432-A7CD9BEF-8285-4E5B-BFCC-2405CC3878AD Q36165673-B4504B90-B3DC-4E24-8BE0-13BAB75570C6 Q36283518-C823B619-E73D-47BF-BA85-5F950CF6BA78 Q36496035-DF87CA1D-E449-4668-99B1-71B95E77BABF Q36818730-31AD2C78-0284-4836-BE54-816A60A5A573 Q36830035-616462E2-36FD-4368-A0EA-3FB3AB76558E Q36831192-3E7D41FA-2C4B-4782-A4B4-CD1E91051D65 Q36895502-F1DA0D0F-FE01-4992-8A43-4DE9B5D52A21 Q36895945-C5BDD821-A42B-4E85-A15F-6A24D8F46EBA Q37008856-74A3EFAA-488C-4B07-AA26-BCEAC7EBE7B5 Q37061179-C3D62BE6-00E9-4490-918D-35DA2F7AC336 Q37597694-ED63382C-DD28-40F4-90D2-F61DC7678CF7 Q37608516-3D73DC27-1AA2-4065-BD70-3552FDB773DA Q37667560-C773D6E0-FC1C-4C12-8245-88F2AF3128D9 Q37692552-5FA564B2-F50F-4701-AA9D-D4C60C2D2DED Q38017897-B90E9BCE-AC07-4BEB-B2EF-CAC89B039C6A Q38026353-B6C2909A-9E51-4A1E-BE9E-CF70F1B8B58F Q38027744-8F019FCD-20FA-4065-A6AE-F3F9ECC8F039 Q38072272-A511B810-70FD-47FF-A7BF-0054DBFB34C4 Q38177920-A36CF742-9187-4A46-874C-B861CABB7F90 Q38708811-CC0F5652-1151-47AD-94B3-25A9CE840AD6

P2860

Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling.

http://www.wikidata.org/entity/Q35015752

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Adiponectin suppresses glucone ...... endent of LKB1-AMPK signaling.

@ast

Adiponectin suppresses glucone ...... endent of LKB1-AMPK signaling.

@en

type

label

Adiponectin suppresses glucone ...... endent of LKB1-AMPK signaling.

@ast

Adiponectin suppresses glucone ...... endent of LKB1-AMPK signaling.

@en

prefLabel

Adiponectin suppresses glucone ...... endent of LKB1-AMPK signaling.

@ast

Adiponectin suppresses glucone ...... endent of LKB1-AMPK signaling.

@en

P1433

Q35015752-8D8C4EC5-54EE-4271-B450-4A997310EE1F

P1476

Q35015752-0F130660-7F0F-4AEA-ABB9-D29EBA8E2406

P2093

Q35015752-14D7C7A0-ADF2-4F8A-A530-D91551AE6668

Q35015752-6CA6DBF5-C9A8-45BC-B86C-D9CAE21AB8F2

Q35015752-8F69A329-A396-4023-864B-D3F2F8208E42

Q35015752-9F41F86E-7788-41A0-8DED-9B432347DAE2

Q35015752-AF0A6DDD-5E18-40B0-9AFF-82F10A023F15

Q35015752-B7BCB684-B76E-4E7E-9C01-C460B9E67590

P2860

Q35015752-02A929C8-B383-4A0A-A66E-375A68F4749F

Q35015752-0870A4C0-320A-4674-B251-539899A02D36

Q35015752-106F265B-2108-4F87-A3BD-98C9D96E8A01

Q35015752-14A0C564-F040-4AAF-B67E-65193EBD6CCC

Q35015752-237A3296-DB07-4D3C-B73F-D1DE757ECC2A

Q35015752-26458348-4399-40D1-801E-6A819DD20CC3

Q35015752-32A148E4-5BC8-4A7E-B374-403B0D75CAEA

Q35015752-3768BC36-774A-424B-AB29-94A56E8A861C

Q35015752-3B111FF0-793E-4AD3-A95E-23E3B14E01ED

Q35015752-47AEA72F-473A-467F-8FFF-B2684F9E87C8

P304

Q35015752-8DC91121-0114-49B2-ADDE-A9A1D6F52F1B

P31

Q35015752-9DCF22E8-C7ED-47CC-9DB1-1A367C66091B

P356

Q35015752-6484DDFC-382E-4DC6-ACBB-DDB36D49FE75

P407

Q35015752-7286F232-4D28-4A50-8309-FB6E4FF4BB62

P433

Q35015752-D4F76CC2-A356-49AD-90F7-8DB885073183

P478

Q35015752-02B0E1D2-71E4-44B8-877C-E6C95C6EF073

P50

Q35015752-148FD88F-C54C-479E-A766-4C428B11E79A

Q35015752-1FEBDA95-5590-45C7-8B1D-4E768FAED52F

Q35015752-B233CC11-4025-440D-9815-FB1AA52D8130

P577

Q35015752-6F3654E4-F62B-4F1C-B129-0B84B85FF954

P698

Q35015752-C5C2F6AA-CF28-4197-9C4F-08FC333762C4

P932

Q35015752-9E51DA2B-288D-405D-A5D3-859B938E4E51

P356

P1433

Journal of Clinical Investigation

P1476

Adiponectin suppresses glucone ...... endent of LKB1-AMPK signaling.

@en

P2093

John Le Lay

http://www.w3.org/2001/XMLSchema#string

Klaus H Kaestner

http://www.w3.org/2001/XMLSchema#string

Philipp E Scherer

http://www.w3.org/2001/XMLSchema#string

Qingwei Chu

http://www.w3.org/2001/XMLSchema#string

Rexford S Ahima

http://www.w3.org/2001/XMLSchema#string

Russell A Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Importance of autophosphorylation at Ser186 in the A-loop of salt inducible kinase 1 for its sustained kinase activity

APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function

The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome

A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange

Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3

P304

2518-2528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI45942

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Morris J. Birnbaum

P577

2011-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21606593

http://www.w3.org/2001/XMLSchema#string

P932

3104763

http://www.w3.org/2001/XMLSchema#string